Founded by CRISPR pioneers David R. Liu, Feng Zhang, and J. Keith Joung, Beam Therapeutics is driven to develop lifelong cures for severe diseases. Their values-centered approach prioritizes people, innovative science, and a vision of delivering lasting solutions to patients in need.
